Literature DB >> 10026343

Chlamydia pneumoniae antibodies are associated with an atherogenic lipid profile.

L J Murray1, D P O'Reilly, G M Ong, C O'Neill, A E Evans, K B Bamford.   

Abstract

OBJECTIVE: To determine, within a representative population group of men and women, whether alteration of the lipid profile might underlie the reported association between Chlamydia pneumoniae and ischaemic heart disease. DESIGN AND
SETTING: Cross sectional survey in an area with a high incidence of ischaemic heart disease.
SUBJECTS: 400 randomly selected participants in the World Health Organisation MONICA project's third population survey in Northern Ireland. MAIN OUTCOME MEASURES: Stored sera were examined by microimmunofluorescence for IgG antibodies to C pneumoniae at a dilution of 1 in 64. Mean total and high density lipoprotein (HDL) cholesterol were compared between seropositive and seronegative individuals with adjustment for age, measures of socioeconomic status, smoking habit, alcohol consumption, body mass index, and the season during which blood had been taken.
RESULTS: In seropositive men, adjusted mean serum total cholesterol and HDL cholesterol were 0.5 mmol/l (9.2%) higher and 0.11 mmol/l (9.3%) lower, respectively, than in seronegative men. Differences in women did not achieve statistical significance, but both total cholesterol and HDL cholesterol were higher (3.6% and 5.8%, respectively) in seropositive than in seronegative individuals.
CONCLUSIONS: There is serological evidence that C pneumoniae infection is associated with an atherogenic lipid profile in men. Altered lipid levels may underlie the association between C pneumoniae and ischaemic heart disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10026343      PMCID: PMC1728950          DOI: 10.1136/hrt.81.3.239

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  59 in total

1.  Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease.

Authors:  D H Thom; J T Grayston; D S Siscovick; S P Wang; N S Weiss; J R Daling
Journal:  JAMA       Date:  1992-07-01       Impact factor: 56.272

2.  Prevalence of antibodies to Chlamydia pneumoniae in a Belgian population.

Authors:  A M Van den Abeele; L Van Renterghem; K Willems; J Plum
Journal:  J Infect       Date:  1992-07       Impact factor: 6.072

Review 3.  Role of cytokines in inducing hyperlipidemia.

Authors:  K R Feingold; C Grunfeld
Journal:  Diabetes       Date:  1992-10       Impact factor: 9.461

4.  Seasonal variation of serum lipids in an elderly population.

Authors:  P R Woodhouse; K T Khaw; M Plummer
Journal:  Age Ageing       Date:  1993-07       Impact factor: 10.668

5.  Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries.

Authors:  C C Kuo; A Shor; L A Campbell; H Fukushi; D L Patton; J T Grayston
Journal:  J Infect Dis       Date:  1993-04       Impact factor: 5.226

6.  Seasonal variation in serum cholesterol levels in health screening populations from the U.K. and Japan.

Authors:  D Robinson; S Hinohara; E A Bevan; T Takahashi
Journal:  J Med Syst       Date:  1993-08       Impact factor: 4.460

7.  Variation in coronary risk factors by social status: results from the Scottish Heart Health Study.

Authors:  M C Shewry; W C Smith; M Woodward; H Tunstall-Pedoe
Journal:  Br J Gen Pract       Date:  1992-10       Impact factor: 5.386

8.  Seasonal variation in plasma cholesterol distributions: implications for screening and referral.

Authors:  L Råstam; P J Hannan; R V Luepker; M B Mittelmark; D M Murray; J S Slater
Journal:  Am J Prev Med       Date:  1992 Nov-Dec       Impact factor: 5.043

9.  Prevalence of antibodies to Chlamydia pneumoniae TWAR in a group of German medical students.

Authors:  H M Freidank; D Brauer
Journal:  J Infect       Date:  1993-07       Impact factor: 6.072

10.  Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979.

Authors:  M B Aldous; J T Grayston; S P Wang; H M Foy
Journal:  J Infect Dis       Date:  1992-09       Impact factor: 5.226

View more
  3 in total

1.  Detection of Chlamydia pneumoniae DNA and antigen in the circulating mononuclear cell fractions of humans and koalas.

Authors:  T J Bodetti; P Timms
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

2.  Non-detection of Chlamydia species in carotid atheroma using generic primers by nested PCR in a population with a high prevalence of Chlamydia pneumoniae antibody.

Authors:  G M Ong; P V Coyle; A A Barros D'Sa; W G McCluggage; W P Duprex; H J O'Neill; D E Wyatt; K B Bamford; B O'Loughlin; C McCaughey
Journal:  BMC Infect Dis       Date:  2001-08-24       Impact factor: 3.090

3.  Microbial risk factors of cardiovascular and cerebrovascular diseases: potential therapeutical options.

Authors:  Mohammed Abdalla Abbas; Albrecht Guenther; Sebastiano Galantucci; Gharib Fawi; Giancarlo Comi; Joseph Kwan; Francesco Corea
Journal:  Open Neurol J       Date:  2008-05-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.